Screen assay-ready plates (ARPS) in the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) nanoluc reporter virus (NLRV) assay
Ended Purchase Order Awarded Last action
- Contract number
- 75N95023P00326
- Awardee
-
Southern Research Institute UEI CDZJAJJHJMH5
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $136,000
Award facts
- Opportunity
-
- Evaluation of PLpro inhibitors in a live virus cell based SARS-CoV2 luciferase reporter assay Pre-Solicitation · 75N95023Q00327 · Posted May 18, 2023
- Contract value 100% obligated
- $136,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Birmingham, AL 35205, USA
Award details come from SAM.gov/FPDS.
About this award
This $136,000 firm fixed price purchase order was awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Southern Research Institute, a non-profit research organization, to screen assay-ready plates in a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nanoluc reporter virus (NLRV) assay. The contract supports the Antiviral Program for Pandemics (APP) initiative to develop treatments for SARS-CoV-2 and other coronaviruses, with a focus on optimizing literature-reported papain-like protease (PLpro) inhibitors. Southern Research Institute has a specialized agreement for the SARS-CoV-2 NLRV assay, which will be conducted in a biosafety level 3 setting. The contract does not have a set-aside designation.
Quick answers
Who was awarded contract 75N95023P00326?
75N95023P00326 was awarded to Southern Research Institute by National Institute on Drug Abuse (National Institutes of Health) on June 5, 2023.
How much is contract 75N95023P00326 worth?
The government has obligated $136,000 on 75N95023P00326.
Which agency awarded contract 75N95023P00326?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95023P00326, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95023P00326 competed?
The extent of competition for 75N95023P00326 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award